The neuroprotective effect of intranasally applied leptin against hypoxic neuronal injury

Medical Hypotheses

Volumn 74, Issue 6, 2010, Pages 1036-1037

  Minciu Macrea, Madalina ^a,b   Misra, Hara ^c   Zagrean, Leon ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^d CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; KAINIC ACID RECEPTOR; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N METHYL DEXTRO ASPARTIC ACID;

APOPTOSIS; ARTICLE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN REGION; CELL LOSS; DRUG TARGETING; ENZYME ACTIVATION; EXCITOTOXICITY; HIPPOCAMPUS; INHIBITION KINETICS; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

ADMINISTRATION, INTRANASAL; ANIMALS; APOPTOSIS; EXCITATORY AMINO ACIDS; HIPPOCAMPUS; HUMANS; HYPOXIA, BRAIN; HYPOXIA-ISCHEMIA, BRAIN; LEPTIN; MAP KINASE SIGNALING SYSTEM; MODELS, NEUROLOGICAL; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS;

EID: 77951622166     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.12.033     Document Type: Article

References (17)

1. Oechmichen M., Messner C. Cerebral hypoxia and ischemia: the forensic point of view: a review. J Forensic Sci 2006, 51(4):880-887.
2. Anderson J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat Rev Neurosci 2004, 5:S18-S25.
3. Haddad J.J. Antioxidant and pro-oxidant mechanisms in the regulation of redox (y) sensitive transcription factors. Cell Signal 2002, 14:879-897.
4. Sharp F.R., Bergeron M., Bernaudin M. Hypoxia-inducible factor in the brain. Adv Exp Med Biol 2001, 502:273-291.
5. Demougeot C., Van Hoecke M., Bernard N. Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2, 2'dipyridil in the rat photo thrombotic ischemic stroke model. J Pharmacol Exp Ther 2004, 311:1080-1087.
6. Devasagayan T.P.A., Tilak J.C., Bollor K.K. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physician India 2004, 52:794-804.
7. Won S.J., Kim D.Y., Gwag B.J. Cellular and molecular pathways of ischemic neuronal death. J Biochem Mol Biol 2002, 35:67-86.
8. Shanley L.J., Irving A.J., Harvey J. Leptin enhanced NMDA receptor functions and modulates hippocampal spasticity. J Neurosci 2001, 21(186):1-6.
9. Zhang F., Wang S., Signore A. Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia. Stroke 2007, 38:2329-2336.
10. Harvey J. Leptin: a diverse regulator of neuronal function. J Neurochem 2007, 100(2):307-313.
11. Dicosu E., Attoub S., Gressens P. Neuroprotective effects of leptin in vivo and in vitro. NeuroReport 2001, 12(18):3947-3951.
12. Demougeot C., Van Hoecke M., Bernard N. Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2, 2'yridil in the rat phototrombotic ischemic stroke model. J Pharmacol Exp Ther 2004, 311:1080-1087.
13. Meissner U., Hanisch C., Ostreicher I. Differential regulation of leptin synthesis in rats during short-term hypoxia and short-term carbon monoxide inhalation. Endocrinology 2005, 146:215-220.
14. Grosfeld A., Andre J., Hauguel-De Mouzon S. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 2002, 277:42953-42957.
15. Bates S.H., Myers M.G. The role of leptin receptor signaling in feeding and neuroendocrine function. Trends Endocrinol Metab 2003, 14:447-452.
16. Russo V.C., Metaxas S., Kobayashi K., Harris M., Werther G.A. Antiapoptotic effects of leptin in human neuroblastoma cells. Endocrinology 2004, 145:4103-4112.
17. Fliedner S., Schulz C., Lehnert H. Brain uptake of intranasally applied radioiodinated leptin in Wistar rats. Endocrinology 2006, 147:2088-2094.